CSF1R and BTK inhibitions as novel strategies to disrupt the dialog between mantle cell lymphoma and macrophages-Reference-Cited by-同舟云学术

CSF1R and BTK inhibitions as novel strategies to disrupt the dialog between mantle cell lymphoma and macrophages

Published:2019-04-02 Issue:10 Volume:33 Page:2442-2453
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Papin Antonin,Tessoulin Benoit,Bellanger Céline,Moreau Anne,Le Bris Yannick,Maisonneuve Hervé,Moreau Philippe,Touzeau Cyrille,Amiot Martine,Pellat-Deceunynck Catherine,Le Gouill Steven,Chiron David

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-019-0463-3.pdf

Reference54 articles.

1. Campo E, Rule S. Mantle cell lymphoma: evolving management strategies. Blood. 2015;125:48–55.

2. Jares P, Colomer D, Campo E. Molecular pathogenesis of mantle cell lymphoma. J Clin Invest. 2012;122:3416–23.

3. Weisenburger DD, Armitage JO. Mantle cell lymphoma—an entity comes of age. Blood. 1996;87:4483–94.

4. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–90.

5. Puente XS, Jares P, Campo E. Chronic lymphocytic leukemia and mantle cell lymphoma: crossroads of genetic and microenvironment interactions. Blood. 2018;131:2283–96.

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review on Role of Inflammation in Coronavirus Disease;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-10

2. CD163+ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression;Blood Advances;2024-08-16

3. Macrophage polarization in the tumor microenvironment: Emerging roles and therapeutic potentials;Biomedicine & Pharmacotherapy;2024-08

4. Dialog between mantle cell lymphoma cells and lymphoma-associated macrophages underlies ibrutinib resistance;Journal of Advanced Research;2024-08

5. Inhibiting Bruton's Tyrosine Kinase to Counteract Chemoresistance and Stem Cell‐Like Properties in Osteosarcoma;Environmental Toxicology;2024-06-26